The role of programmed death ligand-1 and tumor-infiltrating lymphocytes in breast cancer overexpressing HER2 gene

被引：0
|
作者：
Yanchun Li
Mateusz Opyrchal
Song Yao
Xuan Peng
Li Yan
Hossam Jabbour
Thaer Khoury
机构：
[1] Roswell Park Cancer Institute,Department of Pathology
[2] Roswell Park Cancer Institute,Department of Medicine
[3] Roswell Park Cancer Institute,Department of Cancer Prevention and Control
[4] Roswell Park Cancer Institute,Department of Bioinformatics
来源：
Breast Cancer Research and Treatment | 2018年 / 170卷
关键词：
PD-L1; Tumor-infiltrating lymphocytes; HER2 positive breast cancer;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：293 / 302
页数：9
相关论文
共 50 条
  • [41] Clinical Significance of Tumor-Infiltrating T Cells and Programed Death Ligand-1 in Patients with Pancreatic Cancer
    Yoshida, Sayumi
    Ito, Zensho
    Suka, Machi
    Bito, Tsuuse
    Kan, Shin
    Akasu, Takafumi
    Saruta, Masayuki
    Okamoto, Masato
    Kitamura, Hiroaki
    Fujioka, Shuichi
    Misawa, Takeyuki
    Akiba, Tadashi
    Yanagisawa, Hiroyuki
    Sugiyama, Haruo
    Koido, Shigeo
    CANCER INVESTIGATION, 2019, 37 (09) : 463 - 477
  • [42] Expression of Programmed Death Receptor Ligand 1 with High Tumor Infiltrating Lymphocytes Is Associated with Better Prognosis in Breast Cancer
    Bae, Sang Byung
    Cho, Hyun Deuk
    Oh, Mee-Hye
    Lee, Ji-Hye
    Jang, Si-Hyong
    Hong, Soon Auck
    Cho, Junhun
    Kim, Sung Yong
    Han, Sun Wook
    Lee, Jong Eun
    Kim, Han Jo
    Lee, Hyun Ju
    JOURNAL OF BREAST CANCER, 2016, 19 (03) : 242 - 251
  • [43] Classifying Non-Small Cell Lung Cancer by Status of Programmed Cell Death Ligand 1 and Tumor-Infiltrating Lymphocytes on Tumor Cells
    Cui, Shaohua
    Dong, Lili
    Qian, Jialin
    Ye, Lin
    Jiang, Liyan
    JOURNAL OF CANCER, 2018, 9 (01): : 129 - 134
  • [44] Prognostic value of programmed cell death ligand-1 expression in the tumor-infiltrating immune cells of patients with lung cancer: A meta-analysis
    Berele, Birhanu Aberha
    Yang, Guifang
    Wu, Ti
    MOLECULAR AND CLINICAL ONCOLOGY, 2021, 15 (02)
  • [45] Relevance of tumor-infiltrating lymphocytes in breast cancer
    Sathana Dushyanthen
    Paul A. Beavis
    Peter Savas
    Zhi Ling Teo
    Chenhao Zhou
    Mariam Mansour
    Phillip K. Darcy
    Sherene Loi
    BMC Medicine, 13
  • [46] Identification of a neoantigen targeted by tumor-infiltrating lymphocytes in a patient with Her2+breast cancer
    Reimann, H.
    Nguyen, A.
    Huebner, H.
    Erber, R.
    Bausenwein, J.
    Van der Meijden, E. D.
    Lux, M. P.
    Jud, S.
    Griffioen, M.
    Rauh, C.
    Sanborn, J. Z.
    Benz, S. C.
    Rabizadeh, S.
    Beckmann, M. W.
    Mackensen, A.
    Ruebner, M.
    Fasching, P. A.
    Kremer, A. N.
    CANCER RESEARCH, 2019, 79 (04)
  • [47] Relevance of tumor-infiltrating lymphocytes in breast cancer
    Dushyanthen, Sathana
    Beavis, Paul A.
    Savas, Peter
    Teo, Zhi Ling
    Zhou, Chenhao
    Mansour, Mariam
    Darcy, Phillip K.
    Loi, Sherene
    BMC MEDICINE, 2015, 13
  • [48] The presence of programmed death 1 (PD-1)-positive tumor-infiltrating lymphocytes is associated with poor prognosis in human breast cancer
    Muenst, S.
    Soysal, S. D.
    Gao, F.
    Obermann, E. C.
    Oertli, D.
    Gillanders, W. E.
    BREAST CANCER RESEARCH AND TREATMENT, 2013, 139 (03) : 667 - 676
  • [49] The presence of programmed death 1 (PD-1)-positive tumor-infiltrating lymphocytes is associated with poor prognosis in human breast cancer
    S. Muenst
    S. D. Soysal
    F. Gao
    E. C. Obermann
    D. Oertli
    W. E Gillanders
    Breast Cancer Research and Treatment, 2013, 139 : 667 - 676
  • [50] Tumor-infiltrating lymphocytes in HER2-positive breast cancer: potential impact and challenges
    Schlam, I.
    Loi, S.
    Salgado, R.
    Swain, S. M.
    ESMO OPEN, 2025, 10 (02)
12345